Key for UsNext couple of earnings. If the cannimed and medreleaf acquisitions show continued growth in med sales and Pedanios continues to show EU growth, I think the future will be extremely bright. In particular, big money companies will look at us first and foremost now that Constellation has firmly grasped Canopy. Not Aphria, but us. We have all the pieces in place; it is simply a matter of executing and the market for product proving to be as large as we believe. I actually hope that our management does not sign a deal at current price levels - barring of course a very generous price per share offer. I think - if our management team executes on all of the acquisitions over the past 12 months - our SP will climb back to the 11 - 14 dollar range with these earnings reports. That is when I am hoping for a big partner. Not now, not offering under 10 dollars per share. The only way we are below 10 dollars following next earnings report is if these balls are dropped (med sales including EU). I am still waiting to here supply news for Nova Scotia, the province that enjoys MJ use more than any other by percentage. We hired a marketing guy with roots there; getting something done to allow Aurora sales thru their provincial govt and then Aurora retail stores would be a nice little feather in the cap while we (certainly I) wait for these next few quarterlies.